Ralph Charlton
Chief Tech/Sci/R&D Officer at SPRUCE BIOSCIENCES, INC.
Net worth: 38 816 $ as of 30/04/2024
Ralph Charlton active positions
Companies | Position | Start | End |
---|---|---|---|
SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 14/03/2022 | - |
Career history of Ralph Charlton
Former positions of Ralph Charlton
Companies | Position | Start | End |
---|---|---|---|
89BIO, INC. | Chief Tech/Sci/R&D Officer | 01/11/2020 | 01/02/2022 |
Ascendis Pharma, Inc. | Chief Tech/Sci/R&D Officer | 01/05/2019 | 01/11/2020 |
ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 01/07/2018 | 01/05/2019 |
Training of Ralph Charlton
University of Southern California | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SPRUCE BIOSCIENCES, INC. | Health Technology |
89BIO, INC. | Health Technology |
Private companies | 2 |
---|---|
Ascendis Pharma, Inc. | |
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
- Stock Market
- Insiders
- Ralph Charlton
- Experience